Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LESSCOVID: Exogenous Surfactant for COVID-19
NCT04375735Phase 2Completed
- Start
- Nov 2020
- Primary completion
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of BLES in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS). Started Nov 2020; status: completed.
02
Drugs
BLES
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04375735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04375735.